toxic efficacy
4.To test further their efficacy in reversal of advanced, otherwise lethal digoxin toxicity and investigate the possible immunological adverse effects on patients in clinical practice, digoxin specific monoclonal antibody Fab fragments (dig-McAb) and IgGs were used to treat monkeys with threatening digoxin-toxic arrhythmias. All monkeys survived.

